npj Parkinsons Disease

Papers
(The H4-Index of npj Parkinsons Disease is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation306
Current and projected future economic burden of Parkinson’s disease in the U.S.253
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens132
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside109
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells82
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease69
Sex specific cognitive differences in Parkinson disease65
Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life61
Dynamic control of the dopamine transporter in neurotransmission and homeostasis56
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study54
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review53
Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management52
Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings46
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes45
Gait speed in clinical and daily living assessments in Parkinson’s disease patients: performance versus capacity44
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?44
Incidence of Parkinson disease in North America44
Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation43
Multi-modality machine learning predicting Parkinson’s disease42
Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes41
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease41
A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease41
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study40
Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson’s disease39
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease39
Probiotics synergized with conventional regimen in managing Parkinson’s disease38
Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson’s disease37
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies37
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology35
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients34
Stress and mindfulness in Parkinson’s disease – a survey in 5000 patients33
Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease32
0.035000801086426